Kristina Kjellbom

Title: Kristina Kjellbom: Innovator in Pharmaceutical Chemistry

Introduction

Kristina Kjellbom is a notable inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. Her work has implications for the treatment of gastrointestinal disorders, showcasing her impact on healthcare.

Latest Patents

Kristina holds a patent for the invention titled "Omeprazole sodium salt." This invention relates to a novel form of the sodium salt of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-1-benzimidazole, commonly known as omeprazole sodium salt. The patent also covers processes for the preparation of omeprazole sodium form B, which is thermodynamically stable. Additionally, it includes pharmaceutical compositions containing this compound and its use in treating gastrointestinal disorders. She has 1 patent to her name.

Career Highlights

Kristina has been associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to work on innovative solutions that address critical health issues. Her expertise in pharmaceutical chemistry has been instrumental in advancing drug development processes.

Collaborations

One of her notable collaborators is Ingvar Ymén. Their partnership has contributed to the successful development of pharmaceutical innovations.

Conclusion

Kristina Kjellbom's work exemplifies the vital role of inventors in the pharmaceutical industry. Her contributions, particularly in the formulation of omeprazole sodium salt, highlight her commitment to improving healthcare outcomes.